Bullish
The average 12-month price target for Cardinal Health, Inc. (CAH) stock has increased to $248.27 from $246.93, based on estimates from 15 analysts. Th...
Cardinal Health, Inc. (NYSE: CAH) has been removed from the Russell 1000 Growth-Defensive Index, as announced on June 29, 2026. This news follows seve...
Neutral
This article provides financial information for Cardinal Health, Inc. (NYSE: CAH), specifically focusing on its enterprise value to EBITDA forward met...
Neutral
This page provides financial information for Cardinal Health, Inc. Unsponsored Brazilian Depositary Receipt Repr 1 Sh (C1AH34) on the B3 exchange, spe...
Bullish
Cardinal Health's shares are currently trading within a defined technical range on the NYSE, positioned between established support and resistance lev...
Neutral
Brookstone Capital Management boosted its holdings in Cardinal Health, Inc. (NYSE:CAH – Free Report) by 59.5% in the 1st quarter, according to the com...
Cardinal Health (CAH) closed up +1.79% while the S&P 500 fell, and its shares have gained 14.24% over the past month. The company is expected to repor...
Neutral
Cardinal Health (CAH) recently reported strong fiscal third-quarter earnings and raised its outlook, driven by its focus on specialty pharmaceuticals....
Neutral
This article provides a weekly outlook for Cardinal Health stock, noting the absence of fresh company-specific news and directing investors to focus o...
Neutral
Cardinal Health (CAH) stock is considered 9.6% undervalued with a fair value of $245.27, according to an analysis based on detailed earnings projectio...
Bullish
This article analyzes Cardinal Health's long-term strategy and business model, focusing on its role as a key healthcare distributor in the U.S. It del...
Neutral
This article provides a weekly review of Cardinal Health (US14149Y1082) stock, noting a quiet week without significant company news. The focus is on c...
Bullish
Cardinal Health (CAH) stock has gained nearly 8% year-to-date in 2026, building on a 74% gain in 2025, driven by strong earnings, specialty pharmaceut...
Neutral
Recent institutional ownership data and insider transactions for Cardinal Health Inc. (US14149Y1082) have drawn market attention, highlighting how lar...
Neutral
Cardinal Health's stock has seen significant gains, prompting investors to re-evaluate its valuation and fundamental strength. As a major healthcare d...
![[144] CARDINAL HEALTH INC SEC Filing](https://static.stocktitan.net/company-logo/cah.png?v=3befefdc53){kind=logo}
Neutral
This article announces an SEC Form 144 filing by Cardinal Health Inc. (CAH), indicating a proposed sale of securities under Rule 144. The filing provi...
This article lists various Exchange Traded Funds (ETFs) that hold stocks of Cardinal Health, Inc. It provides a detailed table including the ETF symbo...
Bearish
This article compiles several trading ideas for Cardinal Health (XETR:CLH), offering both bullish and bearish perspectives. A key bearish analysis hig...
Neutral
Daiwa Securities Group Inc. trimmed its position in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) by 5.2% during the 4th quarter, according...